

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 8.26391244 |
| 2 | antigen processing and presentation of endogenous antigen (GO:0019883) | 8.01480249 |
| 3 | oxygen transport (GO:0015671) | 7.48016508 |
| 4 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 6.67549458 |
| 5 | NIK/NF-kappaB signaling (GO:0038061) | 6.50726929 |
| 6 | positive regulation of granulocyte chemotaxis (GO:0071624) | 6.43622554 |
| 7 | neurotransmitter catabolic process (GO:0042135) | 6.21780020 |
| 8 | positive regulation of antigen processing and presentation (GO:0002579) | 5.93770514 |
| 9 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.72470339 |
| 10 | virion attachment to host cell (GO:0019062) | 5.54036562 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 5.54036562 |
| 12 | chaperone-mediated protein transport (GO:0072321) | 5.48366797 |
| 13 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 5.25721682 |
| 14 | substrate-independent telencephalic tangential migration (GO:0021826) | 5.25721682 |
| 15 | imidazole-containing compound metabolic process (GO:0052803) | 5.21246400 |
| 16 | positive regulation of natural killer cell differentiation (GO:0032825) | 5.12363626 |
| 17 | tongue development (GO:0043586) | 5.11824355 |
| 18 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 5.03266256 |
| 19 | cellular response to ATP (GO:0071318) | 5.01835018 |
| 20 | regulation of antigen processing and presentation (GO:0002577) | 4.99780591 |
| 21 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.96842874 |
| 22 | pericardium development (GO:0060039) | 4.94922203 |
| 23 | proline transport (GO:0015824) | 4.89910154 |
| 24 | regulation of mitochondrial translation (GO:0070129) | 4.85130682 |
| 25 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.76677708 |
| 26 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.74699753 |
| 27 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 4.73280261 |
| 28 | regulation of mitotic spindle checkpoint (GO:1903504) | 4.73280261 |
| 29 | growth hormone secretion (GO:0030252) | 4.70398219 |
| 30 | regulation of Cdc42 GTPase activity (GO:0043088) | 4.68817104 |
| 31 | positive regulation of growth hormone secretion (GO:0060124) | 4.67852123 |
| 32 | positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568) | 4.64080051 |
| 33 | chromatin remodeling at centromere (GO:0031055) | 4.55398948 |
| 34 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.48808807 |
| 35 | regulation of cellular extravasation (GO:0002691) | 4.43248668 |
| 36 | CENP-A containing nucleosome assembly (GO:0034080) | 4.33395424 |
| 37 | purine nucleobase biosynthetic process (GO:0009113) | 4.31600705 |
| 38 | pharyngeal system development (GO:0060037) | 4.26394344 |
| 39 | adhesion of symbiont to host (GO:0044406) | 4.25644716 |
| 40 | ATP synthesis coupled proton transport (GO:0015986) | 4.24853027 |
| 41 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.24853027 |
| 42 | IMP biosynthetic process (GO:0006188) | 4.14171814 |
| 43 | L-serine metabolic process (GO:0006563) | 4.11263665 |
| 44 | nitric oxide biosynthetic process (GO:0006809) | 4.09276264 |
| 45 | gas transport (GO:0015669) | 4.08164920 |
| 46 | determination of adult lifespan (GO:0008340) | 4.04278010 |
| 47 | establishment of integrated proviral latency (GO:0075713) | 4.04110935 |
| 48 | DNA replication checkpoint (GO:0000076) | 4.03150081 |
| 49 | hemidesmosome assembly (GO:0031581) | 4.02513158 |
| 50 | positive regulation of neutrophil chemotaxis (GO:0090023) | 4.02269365 |
| 51 | positive regulation of neutrophil migration (GO:1902624) | 4.02269365 |
| 52 | positive regulation of receptor biosynthetic process (GO:0010870) | 4.02067902 |
| 53 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 4.01256143 |
| 54 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 4.01256143 |
| 55 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 4.01256143 |
| 56 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 4.01256143 |
| 57 | negative regulation of sister chromatid segregation (GO:0033046) | 4.01256143 |
| 58 | negative regulation of interleukin-10 production (GO:0032693) | 4.01046030 |
| 59 | histone exchange (GO:0043486) | 3.99216859 |
| 60 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.98620834 |
| 61 | termination of RNA polymerase III transcription (GO:0006386) | 3.92409480 |
| 62 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.92409480 |
| 63 | negative regulation of chromosome segregation (GO:0051985) | 3.92113938 |
| 64 | spliceosomal snRNP assembly (GO:0000387) | 3.88732069 |
| 65 | regulation of natural killer cell differentiation (GO:0032823) | 3.88026776 |
| 66 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.87830465 |
| 67 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.82976320 |
| 68 | nucleobase biosynthetic process (GO:0046112) | 3.79838466 |
| 69 | respiratory electron transport chain (GO:0022904) | 3.72753265 |
| 70 | IMP metabolic process (GO:0046040) | 3.71804151 |
| 71 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.71029106 |
| 72 | regulation of gene silencing by miRNA (GO:0060964) | 3.71029106 |
| 73 | regulation of gene silencing by RNA (GO:0060966) | 3.71029106 |
| 74 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.69400826 |
| 75 | proteasome assembly (GO:0043248) | 3.68955257 |
| 76 | regulation of granulocyte chemotaxis (GO:0071622) | 3.67844834 |
| 77 | DNA replication-independent nucleosome organization (GO:0034724) | 3.66089449 |
| 78 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.66089449 |
| 79 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.65811833 |
| 80 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.64860089 |
| 81 | respiratory chain complex IV assembly (GO:0008535) | 3.64790032 |
| 82 | ventricular cardiac muscle cell development (GO:0055015) | 3.62040250 |
| 83 | diaphragm development (GO:0060539) | 3.61295237 |
| 84 | electron transport chain (GO:0022900) | 3.60268568 |
| 85 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.59193515 |
| 86 | serine family amino acid biosynthetic process (GO:0009070) | 3.57084061 |
| 87 | positive regulation of macrophage cytokine production (GO:0060907) | 3.56893621 |
| 88 | regulation of lipoprotein particle clearance (GO:0010984) | 3.56572325 |
| 89 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.54284067 |
| 90 | asymmetric protein localization (GO:0008105) | 3.53696538 |
| 91 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.53285321 |
| 92 | dendritic cell differentiation (GO:0097028) | 3.53070638 |
| 93 | protein complex biogenesis (GO:0070271) | 3.52442892 |
| 94 | cytochrome complex assembly (GO:0017004) | 3.51022563 |
| 95 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.47612669 |
| 96 | membrane tubulation (GO:0097320) | 3.47458981 |
| 97 | synapsis (GO:0007129) | 3.45563041 |
| 98 | activation of Rac GTPase activity (GO:0032863) | 3.44147984 |
| 99 | mitotic spindle assembly checkpoint (GO:0007094) | 3.42338942 |
| 100 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.41841909 |
| 101 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 3.40838963 |
| 102 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 3.40838963 |
| 103 | negative regulation of telomerase activity (GO:0051974) | 3.40144574 |
| 104 | glycine metabolic process (GO:0006544) | 3.39312817 |
| 105 | transcription from mitochondrial promoter (GO:0006390) | 3.38192843 |
| 106 | urea cycle (GO:0000050) | 3.37072795 |
| 107 | urea metabolic process (GO:0019627) | 3.37072795 |
| 108 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36907569 |
| 109 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.36907569 |
| 110 | spindle assembly checkpoint (GO:0071173) | 3.36839271 |
| 111 | mitotic spindle checkpoint (GO:0071174) | 3.35000087 |
| 112 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.33747724 |
| 113 | regulation of monocyte chemotaxis (GO:0090025) | 3.33457315 |
| 114 | alkaloid metabolic process (GO:0009820) | 3.33264174 |
| 115 | spindle checkpoint (GO:0031577) | 3.33054131 |
| 116 | germinal center formation (GO:0002467) | 3.32140000 |
| 117 | regulation of mitotic sister chromatid segregation (GO:0033047) | 3.30325363 |
| 118 | regulation of sister chromatid segregation (GO:0033045) | 3.30325363 |
| 119 | regulation of mitotic sister chromatid separation (GO:0010965) | 3.30325363 |
| 120 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.29351830 |
| 121 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.27124846 |
| 122 | histone mRNA metabolic process (GO:0008334) | 3.26715086 |
| 123 | skeletal muscle organ development (GO:0060538) | 3.25939214 |
| 124 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.25587094 |
| 125 | NADH dehydrogenase complex assembly (GO:0010257) | 3.25587094 |
| 126 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.25587094 |
| 127 | hypothalamus development (GO:0021854) | 3.25311014 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 3.24962045 |
| 129 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 3.24944188 |
| 130 | negative regulation of mitosis (GO:0045839) | 3.23643169 |
| 131 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.23461945 |
| 132 | arginine metabolic process (GO:0006525) | 3.23409622 |
| 133 | embryonic heart tube development (GO:0035050) | 3.21053606 |
| 134 | regulation of helicase activity (GO:0051095) | 3.20796059 |
| 135 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.20032833 |
| 136 | protein neddylation (GO:0045116) | 3.17214298 |
| 137 | protein targeting to mitochondrion (GO:0006626) | 3.16839676 |
| 138 | heterochromatin organization (GO:0070828) | 3.15821894 |
| 139 | serine family amino acid metabolic process (GO:0009069) | 3.09522539 |
| 140 | axonal fasciculation (GO:0007413) | 3.06954688 |
| 141 | DNA strand elongation (GO:0022616) | 3.05421062 |
| 142 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.04944040 |
| 143 | serine family amino acid catabolic process (GO:0009071) | 3.03126814 |
| 144 | regulation of bile acid biosynthetic process (GO:0070857) | 3.02929952 |
| 145 | oxidative phosphorylation (GO:0006119) | 3.00837362 |
| 146 | DNA damage response, detection of DNA damage (GO:0042769) | 3.00582595 |
| 147 | positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261) | 2.98428682 |
| 148 | nitrogen cycle metabolic process (GO:0071941) | 2.97612183 |
| 149 | regulation of growth hormone secretion (GO:0060123) | 2.96252719 |
| 150 | establishment of viral latency (GO:0019043) | 2.93678279 |
| 151 | desmosome organization (GO:0002934) | 2.93561735 |
| 152 | kinetochore organization (GO:0051383) | 2.92547857 |
| 153 | positive regulation of cholesterol efflux (GO:0010875) | 2.92292820 |
| 154 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.91931637 |
| 155 | cellular response to vitamin (GO:0071295) | 2.90999497 |
| 156 | termination of RNA polymerase II transcription (GO:0006369) | 2.90577275 |
| 157 | establishment of protein localization to mitochondrion (GO:0072655) | 2.89857922 |
| 158 | negative regulation of ligase activity (GO:0051352) | 2.89369935 |
| 159 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.89369935 |
| 160 | regulation of chromosome segregation (GO:0051983) | 2.85684542 |
| 161 | mitotic metaphase plate congression (GO:0007080) | 2.84880143 |
| 162 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.84472322 |
| 163 | negative thymic T cell selection (GO:0045060) | 2.83933338 |
| 164 | synaptic transmission, cholinergic (GO:0007271) | 2.83339007 |
| 165 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.83083729 |
| 166 | prostanoid biosynthetic process (GO:0046457) | 2.82540243 |
| 167 | prostaglandin biosynthetic process (GO:0001516) | 2.82540243 |
| 168 | regulation of memory T cell differentiation (GO:0043380) | 2.82239073 |
| 169 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.81995403 |
| 170 | L-fucose catabolic process (GO:0042355) | 2.81801712 |
| 171 | fucose catabolic process (GO:0019317) | 2.81801712 |
| 172 | L-fucose metabolic process (GO:0042354) | 2.81801712 |
| 173 | protein localization to kinetochore (GO:0034501) | 2.81019090 |
| 174 | rRNA modification (GO:0000154) | 2.80212389 |
| 175 | DNA ligation (GO:0006266) | 2.79307906 |
| 176 | protein localization to mitochondrion (GO:0070585) | 2.78750661 |
| 177 | positive regulation of leukocyte chemotaxis (GO:0002690) | 2.78500044 |
| 178 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.77443635 |
| 179 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.77443635 |
| 180 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.77363313 |
| 181 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.77363313 |
| 182 | pseudouridine synthesis (GO:0001522) | 2.76623329 |
| 183 | inner mitochondrial membrane organization (GO:0007007) | 2.76448822 |
| 184 | dendritic cell chemotaxis (GO:0002407) | 2.75543397 |
| 185 | negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435) | 2.74495005 |
| 186 | negative regulation of nuclear division (GO:0051784) | 2.74392786 |
| 187 | pre-miRNA processing (GO:0031054) | 2.74376179 |
| 188 | DNA-templated transcription, termination (GO:0006353) | 2.73731507 |
| 189 | histone H4-K12 acetylation (GO:0043983) | 2.71541859 |
| 190 | regulation of activation of Janus kinase activity (GO:0010533) | 2.70731697 |
| 191 | regulation of macrophage cytokine production (GO:0010935) | 2.69579814 |
| 192 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.69383938 |
| 193 | regulation of neutrophil chemotaxis (GO:0090022) | 2.69163513 |
| 194 | regulation of neutrophil migration (GO:1902622) | 2.69163513 |
| 195 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.66947868 |
| 196 | positive regulation of filopodium assembly (GO:0051491) | 2.64622865 |
| 197 | head development (GO:0060322) | 2.63004372 |
| 198 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.62675635 |
| 199 | positive regulation of cholesterol transport (GO:0032376) | 2.61090200 |
| 200 | positive regulation of sterol transport (GO:0032373) | 2.61090200 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.01707357 |
| 2 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.62815601 |
| 3 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.37122951 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.17036988 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.41627830 |
| 6 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 3.32705559 |
| 7 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.30200296 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.24330682 |
| 9 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.17919898 |
| 10 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.97222787 |
| 11 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.78372006 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.77216769 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.59080241 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53836186 |
| 15 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.49601781 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.45604203 |
| 17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.44746179 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.34509568 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.27502174 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.26030814 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.25342431 |
| 22 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.23499808 |
| 23 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.21738527 |
| 24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.15363817 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.14974131 |
| 26 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.13431081 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11927594 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08212330 |
| 29 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.05233338 |
| 30 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.05233338 |
| 31 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.02563239 |
| 32 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.02454677 |
| 33 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.01729106 |
| 34 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.97427686 |
| 35 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.96983424 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.92618507 |
| 37 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.92378844 |
| 38 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90083852 |
| 39 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.89934480 |
| 40 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88919851 |
| 41 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86914620 |
| 42 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.86802846 |
| 43 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85927487 |
| 44 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.84953229 |
| 45 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.82629858 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.82400032 |
| 47 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.80932048 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80747906 |
| 49 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.79028138 |
| 50 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76549368 |
| 51 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.69324030 |
| 52 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.69206959 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69108621 |
| 54 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.66907248 |
| 55 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65765281 |
| 56 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.65738042 |
| 57 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64210164 |
| 58 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.63446404 |
| 59 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.63446404 |
| 60 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.63446404 |
| 61 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.62720062 |
| 62 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.60769694 |
| 63 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.59492770 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.59464181 |
| 65 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.58950088 |
| 66 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.58216511 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58156481 |
| 68 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.55935449 |
| 69 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.55603896 |
| 70 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.55258124 |
| 71 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.54140433 |
| 72 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.53835749 |
| 73 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.51366274 |
| 74 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.50967136 |
| 75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.46598188 |
| 76 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.45894026 |
| 77 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.45018534 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.43722813 |
| 79 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.41997875 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.41843646 |
| 81 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41093375 |
| 82 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39824549 |
| 83 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.36628967 |
| 84 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35686502 |
| 85 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35686502 |
| 86 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.35464634 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.35283907 |
| 88 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.35109372 |
| 89 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34494252 |
| 90 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34350031 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.34255631 |
| 92 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.33295457 |
| 93 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.32563546 |
| 94 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.32416348 |
| 95 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32232942 |
| 96 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.32015013 |
| 97 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.31488378 |
| 98 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29798440 |
| 99 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29676593 |
| 100 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.29296689 |
| 101 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.26954463 |
| 102 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.26748133 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.24254180 |
| 104 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.23674783 |
| 105 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.23170437 |
| 106 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.22627027 |
| 107 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.22304543 |
| 108 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21456666 |
| 109 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.19166707 |
| 110 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.15631318 |
| 111 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.13892002 |
| 112 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.13755284 |
| 113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13163053 |
| 114 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.12657014 |
| 115 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.11580404 |
| 116 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.11398429 |
| 117 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.09921798 |
| 118 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09419927 |
| 119 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08805805 |
| 120 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.08307461 |
| 121 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.08152856 |
| 122 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 1.06833711 |
| 123 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05775506 |
| 124 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04916588 |
| 125 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.04670133 |
| 126 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.04614817 |
| 127 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04448901 |
| 128 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04347895 |
| 129 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.02054118 |
| 130 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01815071 |
| 131 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01005688 |
| 132 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.00930264 |
| 133 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00368690 |
| 134 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.00052515 |
| 135 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.99661918 |
| 136 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.98976523 |
| 137 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98941306 |
| 138 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.98189842 |
| 139 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97987455 |
| 140 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97639393 |
| 141 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97440246 |
| 142 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95870696 |
| 143 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95628097 |
| 144 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.95530107 |
| 145 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95318274 |
| 146 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94387123 |
| 147 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.93892633 |
| 148 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.93793019 |
| 149 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.93179415 |
| 150 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.92114324 |
| 151 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.91661819 |
| 152 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.91635962 |
| 153 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91389832 |
| 154 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91290564 |
| 155 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.91214124 |
| 156 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90961133 |
| 157 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.90690356 |
| 158 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90516464 |
| 159 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.90013726 |
| 160 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89834179 |
| 161 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89293073 |
| 162 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.89210835 |
| 163 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.88999343 |
| 164 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.88771116 |
| 165 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88264040 |
| 166 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88012180 |
| 167 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87862808 |
| 168 | P300_19829295_ChIP-Seq_ESCs_Human | 0.87768717 |
| 169 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87759795 |
| 170 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.87534827 |
| 171 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.87413632 |
| 172 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.86927617 |
| 173 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86695446 |
| 174 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.86445566 |
| 175 | EWS_26573619_Chip-Seq_HEK293_Human | 0.85775829 |
| 176 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.84940784 |
| 177 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.84234095 |
| 178 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.84185440 |
| 179 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84022820 |
| 180 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.82409663 |
| 181 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.82362952 |
| 182 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.82274955 |
| 183 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.82091265 |
| 184 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.80882219 |
| 185 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.80166417 |
| 186 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80144758 |
| 187 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80144758 |
| 188 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.80139292 |
| 189 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.80130596 |
| 190 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.77300688 |
| 191 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77262196 |
| 192 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.75898723 |
| 193 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75825260 |
| 194 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73653176 |
| 195 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.72890356 |
| 196 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.72006851 |
| 197 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.70857076 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001346_abnormal_lacrimal_gland | 6.03965283 |
| 2 | MP0001348_abnormal_lacrimal_gland | 5.34328370 |
| 3 | MP0002876_abnormal_thyroid_physiology | 5.13793548 |
| 4 | MP0003941_abnormal_skin_development | 4.01618302 |
| 5 | MP0008877_abnormal_DNA_methylation | 3.97071483 |
| 6 | MP0005645_abnormal_hypothalamus_physiol | 3.73677195 |
| 7 | MP0000685_abnormal_immune_system | 3.70291094 |
| 8 | MP0006292_abnormal_olfactory_placode | 3.40067561 |
| 9 | MP0003693_abnormal_embryo_hatching | 3.26511157 |
| 10 | MP0005310_abnormal_salivary_gland | 3.13842102 |
| 11 | MP0008058_abnormal_DNA_repair | 3.09266382 |
| 12 | MP0010094_abnormal_chromosome_stability | 3.06412204 |
| 13 | MP0001873_stomach_inflammation | 3.04285870 |
| 14 | MP0003111_abnormal_nucleus_morphology | 2.83800752 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.73578439 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.71470243 |
| 17 | MP0003136_yellow_coat_color | 2.67221033 |
| 18 | MP0006035_abnormal_mitochondrial_morpho | 2.44541984 |
| 19 | MP0004510_myositis | 2.36894229 |
| 20 | MP0003077_abnormal_cell_cycle | 2.34449694 |
| 21 | MP0003718_maternal_effect | 2.31856974 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.24548572 |
| 23 | MP0006082_CNS_inflammation | 2.23064414 |
| 24 | MP0001188_hyperpigmentation | 2.17924437 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 2.15325125 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 2.15126013 |
| 27 | MP0008007_abnormal_cellular_replicative | 2.14644984 |
| 28 | MP0001293_anophthalmia | 2.13747503 |
| 29 | MP0005365_abnormal_bile_salt | 2.11939345 |
| 30 | MP0003879_abnormal_hair_cell | 2.07198181 |
| 31 | MP0002254_reproductive_system_inflammat | 13.1590091 |
| 32 | MP0009379_abnormal_foot_pigmentation | 1.94810626 |
| 33 | MP0003567_abnormal_fetal_cardiomyocyte | 1.86081190 |
| 34 | MP0008057_abnormal_DNA_replication | 1.85906131 |
| 35 | MP0005367_renal/urinary_system_phenotyp | 1.80609290 |
| 36 | MP0000516_abnormal_urinary_system | 1.80609290 |
| 37 | MP0001501_abnormal_sleep_pattern | 1.78391737 |
| 38 | MP0000383_abnormal_hair_follicle | 1.75130863 |
| 39 | MP0009672_abnormal_birth_weight | 1.74669576 |
| 40 | MP0003186_abnormal_redox_activity | 1.74552656 |
| 41 | MP0005647_abnormal_sex_gland | 1.72539195 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.60525440 |
| 43 | MP0010678_abnormal_skin_adnexa | 1.59328584 |
| 44 | MP0003122_maternal_imprinting | 1.57652431 |
| 45 | MP0002938_white_spotting | 1.56829377 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.56091136 |
| 47 | MP0005332_abnormal_amino_acid | 1.55093542 |
| 48 | MP0000613_abnormal_salivary_gland | 1.54135591 |
| 49 | MP0008932_abnormal_embryonic_tissue | 1.47267946 |
| 50 | MP0002877_abnormal_melanocyte_morpholog | 1.44701301 |
| 51 | MP0004133_heterotaxia | 1.44665802 |
| 52 | MP0001984_abnormal_olfaction | 1.41771490 |
| 53 | MP0001529_abnormal_vocalization | 1.40653698 |
| 54 | MP0003787_abnormal_imprinting | 1.40465706 |
| 55 | MP0008875_abnormal_xenobiotic_pharmacok | 1.32942384 |
| 56 | MP0003806_abnormal_nucleotide_metabolis | 1.25297788 |
| 57 | MP0005377_hearing/vestibular/ear_phenot | 1.23324128 |
| 58 | MP0003878_abnormal_ear_physiology | 1.23324128 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 1.23082169 |
| 60 | MP0001851_eye_inflammation | 1.22865370 |
| 61 | MP0010234_abnormal_vibrissa_follicle | 1.22754446 |
| 62 | MP0005671_abnormal_response_to | 1.21092459 |
| 63 | MP0004019_abnormal_vitamin_homeostasis | 1.20931414 |
| 64 | MP0010352_gastrointestinal_tract_polyps | 1.18126357 |
| 65 | MP0001730_embryonic_growth_arrest | 1.17343799 |
| 66 | MP0002735_abnormal_chemical_nociception | 1.16792729 |
| 67 | MP0003121_genomic_imprinting | 1.15754925 |
| 68 | MP0003011_delayed_dark_adaptation | 1.15304308 |
| 69 | MP0003763_abnormal_thymus_physiology | 1.14662980 |
| 70 | MP0006072_abnormal_retinal_apoptosis | 1.14547805 |
| 71 | MP0005360_urolithiasis | 1.14102292 |
| 72 | MP0003786_premature_aging | 1.13567642 |
| 73 | MP0000350_abnormal_cell_proliferation | 1.10409382 |
| 74 | MP0002210_abnormal_sex_determination | 1.09574539 |
| 75 | MP0001929_abnormal_gametogenesis | 1.08180206 |
| 76 | MP0001790_abnormal_immune_system | 1.07408344 |
| 77 | MP0005387_immune_system_phenotype | 1.07408344 |
| 78 | MP0003123_paternal_imprinting | 1.06792562 |
| 79 | MP0002653_abnormal_ependyma_morphology | 1.05887677 |
| 80 | MP0010030_abnormal_orbit_morphology | 1.05642887 |
| 81 | MP0000538_abnormal_urinary_bladder | 1.05088460 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.04530479 |
| 83 | MP0003183_abnormal_peptide_metabolism | 1.03118727 |
| 84 | MP0001145_abnormal_male_reproductive | 1.02866951 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.02007527 |
| 86 | MP0003119_abnormal_digestive_system | 0.99290056 |
| 87 | MP0001666_abnormal_nutrient_absorption | 0.97266496 |
| 88 | MP0000470_abnormal_stomach_morphology | 0.96774304 |
| 89 | MP0000313_abnormal_cell_death | 0.95428748 |
| 90 | MP0003698_abnormal_male_reproductive | 0.93350629 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.93305359 |
| 92 | MP0001286_abnormal_eye_development | 0.91939964 |
| 93 | MP0002090_abnormal_vision | 0.91808998 |
| 94 | MP0005395_other_phenotype | 0.90211515 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.88631071 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.88228586 |
| 97 | MP0005499_abnormal_olfactory_system | 0.88228586 |
| 98 | MP0001881_abnormal_mammary_gland | 0.87765000 |
| 99 | MP0001697_abnormal_embryo_size | 0.87187702 |
| 100 | MP0003938_abnormal_ear_development | 0.86389361 |
| 101 | MP0000653_abnormal_sex_gland | 0.86146446 |
| 102 | MP0002085_abnormal_embryonic_tissue | 0.84622544 |
| 103 | MP0004142_abnormal_muscle_tone | 0.83993709 |
| 104 | MP0005670_abnormal_white_adipose | 0.83392219 |
| 105 | MP0000049_abnormal_middle_ear | 0.83000784 |
| 106 | MP0003137_abnormal_impulse_conducting | 0.81974576 |
| 107 | MP0003937_abnormal_limbs/digits/tail_de | 0.81236313 |
| 108 | MP0002697_abnormal_eye_size | 0.80066047 |
| 109 | MP0002796_impaired_skin_barrier | 0.79747250 |
| 110 | MP0009703_decreased_birth_body | 0.79410966 |
| 111 | MP0003959_abnormal_lean_body | 0.78777300 |
| 112 | MP0003638_abnormal_response/metabolism_ | 0.78657546 |
| 113 | MP0009745_abnormal_behavioral_response | 0.75813450 |
| 114 | MP0002160_abnormal_reproductive_system | 0.75499787 |
| 115 | MP0005084_abnormal_gallbladder_morpholo | 0.73140053 |
| 116 | MP0005379_endocrine/exocrine_gland_phen | 0.72842865 |
| 117 | MP0000579_abnormal_nail_morphology | 0.72351663 |
| 118 | MP0002084_abnormal_developmental_patter | 0.71095356 |
| 119 | MP0005551_abnormal_eye_electrophysiolog | 0.70204886 |
| 120 | MP0002233_abnormal_nose_morphology | 0.69835458 |
| 121 | MP0002736_abnormal_nociception_after | 0.69567182 |
| 122 | MP0009697_abnormal_copulation | 0.67496900 |
| 123 | MP0010155_abnormal_intestine_physiology | 0.67189761 |
| 124 | MP0000427_abnormal_hair_cycle | 0.67061926 |
| 125 | MP0001986_abnormal_taste_sensitivity | 0.66391080 |
| 126 | MP0002148_abnormal_hypersensitivity_rea | 0.65424242 |
| 127 | MP0005380_embryogenesis_phenotype | 0.64672307 |
| 128 | MP0001672_abnormal_embryogenesis/_devel | 0.64672307 |
| 129 | MP0003252_abnormal_bile_duct | 0.64030041 |
| 130 | MP0002111_abnormal_tail_morphology | 0.63655089 |
| 131 | MP0002080_prenatal_lethality | 0.63068459 |
| 132 | MP0002249_abnormal_larynx_morphology | 0.62916341 |
| 133 | MP0003045_fibrosis | 0.62007091 |
| 134 | MP0002909_abnormal_adrenal_gland | 0.61646770 |
| 135 | MP0005000_abnormal_immune_tolerance | 0.61551930 |
| 136 | MP0008872_abnormal_physiological_respon | 0.61431452 |
| 137 | MP0002733_abnormal_thermal_nociception | 0.60202396 |
| 138 | MP0002734_abnormal_mechanical_nocicepti | 0.59224582 |
| 139 | MP0002693_abnormal_pancreas_physiology | 0.58968028 |
| 140 | MP0000604_amyloidosis | 0.58488246 |
| 141 | MP0002405_respiratory_system_inflammati | 0.57920274 |
| 142 | MP0002098_abnormal_vibrissa_morphology | 0.57754165 |
| 143 | MP0000733_abnormal_muscle_development | 0.55406750 |
| 144 | MP0004859_abnormal_synaptic_plasticity | 0.52216614 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.52171838 |
| 146 | MP0001853_heart_inflammation | 0.51327748 |
| 147 | MP0003075_altered_response_to | 0.51227794 |
| 148 | MP0003329_amyloid_beta_deposits | 0.49726261 |
| 149 | MP0003195_calcinosis | 0.49353512 |
| 150 | MP0006276_abnormal_autonomic_nervous | 0.48479850 |
| 151 | MP0001663_abnormal_digestive_system | 0.48344764 |
| 152 | MP0001800_abnormal_humoral_immune | 0.46572979 |
| 153 | MP0005025_abnormal_response_to | 0.46530236 |
| 154 | MP0000003_abnormal_adipose_tissue | 0.46141618 |
| 155 | MP0005197_abnormal_uvea_morphology | 0.45295762 |
| 156 | MP0003300_gastrointestinal_ulcer | 0.44676616 |
| 157 | MP0001216_abnormal_epidermal_layer | 0.42413530 |
| 158 | MP0003705_abnormal_hypodermis_morpholog | 0.41165255 |
| 159 | MP0004270_analgesia | 0.40925007 |
| 160 | MP0002060_abnormal_skin_morphology | 0.39216747 |
| 161 | MP0000467_abnormal_esophagus_morphology | 0.39081994 |
| 162 | * MP0000703_abnormal_thymus_morphology | 0.38243579 |
| 163 | MP0001440_abnormal_grooming_behavior | 0.38231241 |
| 164 | MP0008789_abnormal_olfactory_epithelium | 0.38186999 |
| 165 | MP0004947_skin_inflammation | 0.37024996 |
| 166 | MP0008874_decreased_physiological_sensi | 0.36871629 |
| 167 | MP0004858_abnormal_nervous_system | 0.36538691 |
| 168 | MP0005623_abnormal_meninges_morphology | 0.35311197 |
| 169 | MP0005023_abnormal_wound_healing | 0.34430302 |
| 170 | MP0003091_abnormal_cell_migration | 0.34266630 |
| 171 | MP0005535_abnormal_body_temperature | 0.34206644 |
| 172 | MP0001764_abnormal_homeostasis | 0.33809218 |
| 173 | MP0005381_digestive/alimentary_phenotyp | 0.33623470 |
| 174 | MP0002837_dystrophic_cardiac_calcinosis | 0.32632570 |
| 175 | MP0010771_integument_phenotype | 0.32448029 |
| 176 | MP0003303_peritoneal_inflammation | 0.31904510 |
| 177 | MP0000639_abnormal_adrenal_gland | 0.31665757 |
| 178 | MP0000627_abnormal_mammary_gland | 0.31487101 |
| 179 | MP0002971_abnormal_brown_adipose | 0.31469637 |
| 180 | MP0008569_lethality_at_weaning | 0.31212272 |
| 181 | MP0009046_muscle_twitch | 0.30276291 |
| 182 | MP0004885_abnormal_endolymph | 0.30151180 |
| 183 | MP0009765_abnormal_xenobiotic_induced | 0.30106816 |
| 184 | MP0003448_altered_tumor_morphology | 0.29535036 |
| 185 | MP0002272_abnormal_nervous_system | 0.27657511 |
| 186 | MP0000762_abnormal_tongue_morphology | 0.27641653 |
| 187 | MP0004782_abnormal_surfactant_physiolog | 0.27527402 |
| 188 | MP0001970_abnormal_pain_threshold | 0.26805476 |
| 189 | MP0003635_abnormal_synaptic_transmissio | 0.26357116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic mucocutaneous candidiasis (HP:0002728) | 9.39360267 |
| 2 | Recurrent cutaneous fungal infections (HP:0011370) | 9.39360267 |
| 3 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 6.94661393 |
| 4 | Keratoconjunctivitis (HP:0001096) | 6.71989277 |
| 5 | Asplenia (HP:0001746) | 6.29296115 |
| 6 | Congenital malformation of the right heart (HP:0011723) | 5.96860522 |
| 7 | Double outlet right ventricle (HP:0001719) | 5.96860522 |
| 8 | Right ventricular cardiomyopathy (HP:0011663) | 5.38365064 |
| 9 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 5.22363632 |
| 10 | Type I diabetes mellitus (HP:0100651) | 5.08261350 |
| 11 | Colon cancer (HP:0003003) | 4.94102125 |
| 12 | Hypercortisolism (HP:0001578) | 4.92149364 |
| 13 | Recurrent fungal infections (HP:0002841) | 4.85123165 |
| 14 | Recurrent skin infections (HP:0001581) | 4.68312998 |
| 15 | Eczematoid dermatitis (HP:0000976) | 4.67035340 |
| 16 | Abnormality of the gastric mucosa (HP:0004295) | 4.52122427 |
| 17 | Lip pit (HP:0100267) | 4.11825519 |
| 18 | Severe visual impairment (HP:0001141) | 4.11064510 |
| 19 | Onycholysis (HP:0001806) | 4.08021422 |
| 20 | Hypoplasia of dental enamel (HP:0006297) | 3.80730376 |
| 21 | Acute necrotizing encephalopathy (HP:0006965) | 3.78556400 |
| 22 | Xerostomia (HP:0000217) | 3.78308151 |
| 23 | Truncus arteriosus (HP:0001660) | 3.78019669 |
| 24 | Cholelithiasis (HP:0001081) | 3.76807443 |
| 25 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.75506448 |
| 26 | Prolonged partial thromboplastin time (HP:0003645) | 3.72161614 |
| 27 | Hypoparathyroidism (HP:0000829) | 3.71739455 |
| 28 | Milia (HP:0001056) | 3.69512413 |
| 29 | Acute encephalopathy (HP:0006846) | 3.58101739 |
| 30 | Hepatitis (HP:0012115) | 3.55907942 |
| 31 | Increased hepatocellular lipid droplets (HP:0006565) | 3.50908096 |
| 32 | Plantar hyperkeratosis (HP:0007556) | 3.45194229 |
| 33 | Hyperglycinemia (HP:0002154) | 3.42230749 |
| 34 | Abnormal gallbladder morphology (HP:0012437) | 3.41260896 |
| 35 | Septo-optic dysplasia (HP:0100842) | 3.41240226 |
| 36 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.24998966 |
| 37 | Upper limb muscle weakness (HP:0003484) | 3.21864128 |
| 38 | Abnormality of the labia minora (HP:0012880) | 3.21498684 |
| 39 | Colitis (HP:0002583) | 3.21019681 |
| 40 | Hyperglycinuria (HP:0003108) | 3.20663383 |
| 41 | Lipid accumulation in hepatocytes (HP:0006561) | 3.19566119 |
| 42 | Abnormal pupillary function (HP:0007686) | 3.07285741 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 3.06503404 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.06503404 |
| 45 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 3.04632443 |
| 46 | Type 2 muscle fiber atrophy (HP:0003554) | 3.03608126 |
| 47 | Mitochondrial inheritance (HP:0001427) | 3.01158931 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.96116112 |
| 49 | Abnormality of the neuromuscular junction (HP:0003398) | 2.94585946 |
| 50 | Fatigable weakness (HP:0003473) | 2.94585946 |
| 51 | Agammaglobulinemia (HP:0004432) | 2.91811663 |
| 52 | Hydroxyprolinuria (HP:0003080) | 2.90950177 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.90950177 |
| 54 | Panhypogammaglobulinemia (HP:0003139) | 2.90925709 |
| 55 | Increased CSF lactate (HP:0002490) | 2.85720948 |
| 56 | Interstitial pulmonary disease (HP:0006530) | 2.82165592 |
| 57 | Increased IgE level (HP:0003212) | 2.82057187 |
| 58 | Birth length less than 3rd percentile (HP:0003561) | 2.80394078 |
| 59 | Cerebral edema (HP:0002181) | 2.76757246 |
| 60 | Unilateral renal agenesis (HP:0000122) | 2.74127917 |
| 61 | Keratitis (HP:0000491) | 2.72212881 |
| 62 | Renal Fanconi syndrome (HP:0001994) | 2.67854622 |
| 63 | Muscle fiber atrophy (HP:0100295) | 2.64800282 |
| 64 | Alacrima (HP:0000522) | 2.64349634 |
| 65 | Megaloblastic anemia (HP:0001889) | 2.63690788 |
| 66 | Atrophic scars (HP:0001075) | 2.62437514 |
| 67 | Abnormality of serum amino acid levels (HP:0003112) | 2.60620334 |
| 68 | Reticulocytopenia (HP:0001896) | 2.58844829 |
| 69 | Macrocytic anemia (HP:0001972) | 2.57511093 |
| 70 | Palmoplantar hyperkeratosis (HP:0000972) | 2.55353280 |
| 71 | Abnormal lung lobation (HP:0002101) | 2.54969739 |
| 72 | Transposition of the great arteries (HP:0001669) | 2.54016653 |
| 73 | Abnormal connection of the cardiac segments (HP:0011545) | 2.54016653 |
| 74 | Abnormal ventriculo-arterial connection (HP:0011563) | 2.54016653 |
| 75 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.52794947 |
| 76 | Hypoplasia of the fovea (HP:0007750) | 2.52794947 |
| 77 | IgM deficiency (HP:0002850) | 2.52362504 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.52238993 |
| 79 | Fragile nails (HP:0001808) | 2.52087567 |
| 80 | Amelogenesis imperfecta (HP:0000705) | 2.49651090 |
| 81 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.47741497 |
| 82 | Villous atrophy (HP:0011473) | 2.47741497 |
| 83 | Abnormal number of erythroid precursors (HP:0012131) | 2.46216923 |
| 84 | Methylmalonic acidemia (HP:0002912) | 2.44775171 |
| 85 | Tongue fasciculations (HP:0001308) | 2.43436330 |
| 86 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.43159918 |
| 87 | Abnormality of homocysteine metabolism (HP:0010919) | 2.40708797 |
| 88 | Homocystinuria (HP:0002156) | 2.40708797 |
| 89 | Hypobetalipoproteinemia (HP:0003563) | 2.40561226 |
| 90 | Weak cry (HP:0001612) | 2.40406446 |
| 91 | Nasal polyposis (HP:0100582) | 2.39531875 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 2.37388570 |
| 93 | Adrenal overactivity (HP:0002717) | 2.36580749 |
| 94 | Hypoglycemic seizures (HP:0002173) | 2.36136949 |
| 95 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35967319 |
| 96 | Exertional dyspnea (HP:0002875) | 2.35102804 |
| 97 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.34420064 |
| 98 | Palmar hyperkeratosis (HP:0010765) | 2.32831719 |
| 99 | Methylmalonic aciduria (HP:0012120) | 2.30925753 |
| 100 | Gastrointestinal stroma tumor (HP:0100723) | 2.29405086 |
| 101 | Multiple enchondromatosis (HP:0005701) | 2.29374869 |
| 102 | 3-Methylglutaconic aciduria (HP:0003535) | 2.28941659 |
| 103 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27167701 |
| 104 | Hepatocellular necrosis (HP:0001404) | 2.25177480 |
| 105 | Gastrointestinal inflammation (HP:0004386) | 2.24384280 |
| 106 | Mixed hearing impairment (HP:0000410) | 2.24049956 |
| 107 | Periauricular skin pits (HP:0100277) | 2.23031781 |
| 108 | Preauricular pit (HP:0004467) | 2.23031781 |
| 109 | Hypoglycemic coma (HP:0001325) | 2.22432413 |
| 110 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.21953195 |
| 111 | Meckel diverticulum (HP:0002245) | 2.21174154 |
| 112 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.20298375 |
| 113 | Optic nerve hypoplasia (HP:0000609) | 2.16859526 |
| 114 | Microvesicular hepatic steatosis (HP:0001414) | 2.16793461 |
| 115 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.16416578 |
| 116 | Muscle fibrillation (HP:0010546) | 2.15415193 |
| 117 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.14922227 |
| 118 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.14922227 |
| 119 | Viral hepatitis (HP:0006562) | 2.13505043 |
| 120 | Nasolacrimal duct obstruction (HP:0000579) | 2.12704622 |
| 121 | Type II lissencephaly (HP:0007260) | 2.11980897 |
| 122 | Cleft eyelid (HP:0000625) | 2.11239423 |
| 123 | Congenital stationary night blindness (HP:0007642) | 2.11122437 |
| 124 | Abnormal auditory evoked potentials (HP:0006958) | 2.09805602 |
| 125 | Neoplasm of the colon (HP:0100273) | 2.09746140 |
| 126 | Increased intramyocellular lipid droplets (HP:0012240) | 2.08649703 |
| 127 | Pili torti (HP:0003777) | 2.08388170 |
| 128 | Nail dystrophy (HP:0008404) | 2.07567259 |
| 129 | Abnormality of the gallbladder (HP:0005264) | 2.07006311 |
| 130 | Respiratory difficulties (HP:0002880) | 2.06334380 |
| 131 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.05952534 |
| 132 | Chronic otitis media (HP:0000389) | 2.05939850 |
| 133 | Leukodystrophy (HP:0002415) | 2.03454946 |
| 134 | Glycosuria (HP:0003076) | 2.03095172 |
| 135 | Abnormality of urine glucose concentration (HP:0011016) | 2.03095172 |
| 136 | Increased serum lactate (HP:0002151) | 2.02792479 |
| 137 | Abnormality of the fovea (HP:0000493) | 2.02760709 |
| 138 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02412346 |
| 139 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.02312559 |
| 140 | Abnormality of the ileum (HP:0001549) | 2.02122805 |
| 141 | Chromsome breakage (HP:0040012) | 2.02115949 |
| 142 | Palpitations (HP:0001962) | 2.01523581 |
| 143 | Hepatic necrosis (HP:0002605) | 2.01098042 |
| 144 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00674327 |
| 145 | Neurofibrillary tangles (HP:0002185) | 2.00113805 |
| 146 | Decreased lacrimation (HP:0000633) | 1.99194279 |
| 147 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.99056896 |
| 148 | Maternal diabetes (HP:0009800) | 1.98990353 |
| 149 | Lactic acidosis (HP:0003128) | 1.98059849 |
| 150 | Hyperphosphaturia (HP:0003109) | 1.97726716 |
| 151 | Aplastic anemia (HP:0001915) | 1.95796027 |
| 152 | Anophthalmia (HP:0000528) | 1.95048566 |
| 153 | Premature loss of primary teeth (HP:0006323) | 1.94767914 |
| 154 | Choanal stenosis (HP:0000452) | 1.94194305 |
| 155 | Pallor (HP:0000980) | 1.93359515 |
| 156 | Aplasia cutis congenita (HP:0001057) | 1.93185834 |
| 157 | Hematochezia (HP:0002573) | 1.93008545 |
| 158 | Pustule (HP:0200039) | 1.92256867 |
| 159 | Abnormality of the lacrimal duct (HP:0011481) | 1.92009215 |
| 160 | Woolly hair (HP:0002224) | 1.91821100 |
| 161 | Abnormality of chromosome stability (HP:0003220) | 1.91475797 |
| 162 | Skin pits (HP:0100276) | 1.90913136 |
| 163 | Onion bulb formation (HP:0003383) | 1.90503048 |
| 164 | Abnormality of placental membranes (HP:0011409) | 1.89997725 |
| 165 | Amniotic constriction ring (HP:0009775) | 1.89997725 |
| 166 | Absent septum pellucidum (HP:0001331) | 1.88122940 |
| 167 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87776514 |
| 168 | Central scotoma (HP:0000603) | 1.87040707 |
| 169 | Esophageal varix (HP:0002040) | 1.87004156 |
| 170 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.85975417 |
| 171 | Cellular immunodeficiency (HP:0005374) | 1.85819888 |
| 172 | Lymphopenia (HP:0001888) | 1.84877875 |
| 173 | Lethargy (HP:0001254) | 1.84245995 |
| 174 | Gingivitis (HP:0000230) | 1.83547186 |
| 175 | Abnormal biliary tract physiology (HP:0012439) | 1.83026520 |
| 176 | Bile duct proliferation (HP:0001408) | 1.83026520 |
| 177 | Confusion (HP:0001289) | 1.81497240 |
| 178 | Cerebral inclusion bodies (HP:0100314) | 1.81461795 |
| 179 | Primary adrenal insufficiency (HP:0008207) | 1.81194356 |
| 180 | Osteomalacia (HP:0002749) | 1.80775967 |
| 181 | Abnormality of the nasal mucosa (HP:0000433) | 1.80458889 |
| 182 | Exercise intolerance (HP:0003546) | 1.80310277 |
| 183 | Recurrent bacterial skin infections (HP:0005406) | 1.80200010 |
| 184 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.80104984 |
| 185 | Bilateral microphthalmos (HP:0007633) | 1.78746760 |
| 186 | Abnormality of renal resorption (HP:0011038) | 1.78506076 |
| 187 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.78268776 |
| 188 | Easy fatigability (HP:0003388) | 1.77659095 |
| 189 | Ventricular tachycardia (HP:0004756) | 1.77502056 |
| 190 | Type I transferrin isoform profile (HP:0003642) | 1.77391120 |
| 191 | Calf muscle hypertrophy (HP:0008981) | 1.75927033 |
| 192 | Recurrent sinusitis (HP:0011108) | 1.75820440 |
| 193 | Fragile skin (HP:0001030) | 1.73857141 |
| 194 | Abnormality of vitamin metabolism (HP:0100508) | 1.73704683 |
| 195 | Spontaneous abortion (HP:0005268) | 1.73688829 |
| 196 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.73127345 |
| 197 | Decreased muscle mass (HP:0003199) | 1.68533225 |
| 198 | Rectal prolapse (HP:0002035) | 1.67903350 |
| 199 | Urticaria (HP:0001025) | 1.62103326 |
| 200 | Hypoplasia of the uterus (HP:0000013) | 1.60591800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.57128056 |
| 2 | EPHA3 | 5.13783743 |
| 3 | CDK19 | 4.89192171 |
| 4 | BUB1 | 4.17450568 |
| 5 | CDC7 | 4.03380934 |
| 6 | VRK2 | 3.79938075 |
| 7 | EPHB1 | 3.73147178 |
| 8 | FGFR4 | 3.51762666 |
| 9 | NME1 | 3.50490580 |
| 10 | TTK | 3.11007122 |
| 11 | NLK | 3.02435066 |
| 12 | ZAK | 2.94982174 |
| 13 | MAPK15 | 2.82488124 |
| 14 | TAF1 | 2.50941653 |
| 15 | DYRK3 | 2.29120303 |
| 16 | STK16 | 2.23856412 |
| 17 | MAP3K13 | 2.17070582 |
| 18 | MKNK2 | 2.02473847 |
| 19 | PLK3 | 1.97435669 |
| 20 | TYK2 | 1.94642413 |
| 21 | WNK3 | 1.92169700 |
| 22 | VRK1 | 1.91409286 |
| 23 | PTK6 | 1.86619888 |
| 24 | BMPR1B | 1.82567487 |
| 25 | JAK3 | 1.82534888 |
| 26 | IRAK4 | 1.80006075 |
| 27 | PBK | 1.73620147 |
| 28 | TSSK6 | 1.65541630 |
| 29 | FGFR3 | 1.64395975 |
| 30 | SRPK1 | 1.61963767 |
| 31 | FER | 1.61470707 |
| 32 | PLK1 | 1.56385778 |
| 33 | CDC42BPA | 1.55115665 |
| 34 | MAP3K9 | 1.51008360 |
| 35 | MAP2K2 | 1.50866677 |
| 36 | DYRK1B | 1.46865958 |
| 37 | NEK1 | 1.46360199 |
| 38 | STK38L | 1.46054834 |
| 39 | PLK4 | 1.43079639 |
| 40 | GRK5 | 1.42483176 |
| 41 | ITK | 1.40528205 |
| 42 | BRD4 | 1.36624294 |
| 43 | PRKCI | 1.36075231 |
| 44 | CHUK | 1.35628047 |
| 45 | ERBB3 | 1.34174504 |
| 46 | IKBKE | 1.31617369 |
| 47 | TGFBR1 | 1.27827527 |
| 48 | NTRK1 | 1.25470749 |
| 49 | BTK | 1.24539457 |
| 50 | ATR | 1.24444576 |
| 51 | MAP3K10 | 1.21668630 |
| 52 | JAK2 | 1.19812343 |
| 53 | BCR | 1.17579460 |
| 54 | JAK1 | 1.16706869 |
| 55 | EPHA2 | 1.12881274 |
| 56 | MAP3K7 | 1.11696687 |
| 57 | NME2 | 1.08891274 |
| 58 | MST4 | 1.08753795 |
| 59 | MAP4K1 | 1.07378523 |
| 60 | SCYL2 | 1.06647979 |
| 61 | CSNK1G1 | 1.05724561 |
| 62 | NUAK1 | 1.05593478 |
| 63 | DDR2 | 1.05019933 |
| 64 | TBK1 | 1.04803107 |
| 65 | GRK1 | 1.03912701 |
| 66 | TLK1 | 1.02471820 |
| 67 | TNIK | 1.02372893 |
| 68 | STK4 | 1.01834452 |
| 69 | NEK2 | 1.01164204 |
| 70 | PTK2 | 0.99100245 |
| 71 | CHEK2 | 0.97787270 |
| 72 | MATK | 0.97475022 |
| 73 | CSNK1G2 | 0.96925005 |
| 74 | CASK | 0.96403152 |
| 75 | DAPK2 | 0.95180136 |
| 76 | IKBKB | 0.90857968 |
| 77 | RPS6KB2 | 0.90831915 |
| 78 | STK11 | 0.88865353 |
| 79 | LRRK2 | 0.88643137 |
| 80 | OXSR1 | 0.84297786 |
| 81 | AURKB | 0.83466667 |
| 82 | FGR | 0.82347427 |
| 83 | CDK8 | 0.81422436 |
| 84 | IRAK1 | 0.79367493 |
| 85 | ATM | 0.78916766 |
| 86 | BMPR2 | 0.75920142 |
| 87 | DYRK1A | 0.75688460 |
| 88 | CDK3 | 0.75008541 |
| 89 | CHEK1 | 0.74039058 |
| 90 | INSRR | 0.73074112 |
| 91 | PRKCG | 0.71328854 |
| 92 | EIF2AK3 | 0.71119398 |
| 93 | STK24 | 0.69867722 |
| 94 | ACVR1B | 0.68798020 |
| 95 | DYRK2 | 0.67473660 |
| 96 | SIK3 | 0.66061773 |
| 97 | MELK | 0.65790344 |
| 98 | CSNK1G3 | 0.64995461 |
| 99 | BLK | 0.64577367 |
| 100 | SIK2 | 0.62882294 |
| 101 | PNCK | 0.62784655 |
| 102 | MAPKAPK5 | 0.62483354 |
| 103 | CSF1R | 0.62280217 |
| 104 | MAP2K6 | 0.62059531 |
| 105 | BMX | 0.61152340 |
| 106 | TYRO3 | 0.60804702 |
| 107 | CSNK1A1L | 0.60667918 |
| 108 | CSNK2A2 | 0.60238023 |
| 109 | PASK | 0.59632946 |
| 110 | SIK1 | 0.59397459 |
| 111 | BRSK2 | 0.59301956 |
| 112 | CSNK1E | 0.58647964 |
| 113 | CAMK2G | 0.57360410 |
| 114 | FGFR1 | 0.57121069 |
| 115 | PRKD3 | 0.56447907 |
| 116 | SYK | 0.55418150 |
| 117 | CSNK2A1 | 0.55376988 |
| 118 | PDGFRA | 0.54239961 |
| 119 | MARK1 | 0.52689646 |
| 120 | ALK | 0.52658066 |
| 121 | CDK12 | 0.51747571 |
| 122 | CDK1 | 0.50742303 |
| 123 | STK3 | 0.49809791 |
| 124 | BRSK1 | 0.49806747 |
| 125 | TEC | 0.49666557 |
| 126 | TNK2 | 0.48821535 |
| 127 | HCK | 0.48686955 |
| 128 | BRAF | 0.48524753 |
| 129 | FGFR2 | 0.47084385 |
| 130 | CDK2 | 0.46929506 |
| 131 | TRIM28 | 0.46317326 |
| 132 | ARAF | 0.46053797 |
| 133 | CDK9 | 0.45764202 |
| 134 | MARK3 | 0.45651281 |
| 135 | EPHA4 | 0.45455116 |
| 136 | RET | 0.45266020 |
| 137 | CDK7 | 0.44776365 |
| 138 | IRAK3 | 0.44174407 |
| 139 | RIPK4 | 0.43564780 |
| 140 | UHMK1 | 0.43381601 |
| 141 | CDK4 | 0.42349024 |
| 142 | AURKA | 0.42090582 |
| 143 | CSNK1A1 | 0.41797158 |
| 144 | PRKCE | 0.41722406 |
| 145 | HIPK2 | 0.41513215 |
| 146 | PRKDC | 0.40505052 |
| 147 | SRC | 0.40414930 |
| 148 | LMTK2 | 0.39373909 |
| 149 | PRKCD | 0.39085070 |
| 150 | DAPK1 | 0.39072379 |
| 151 | CAMK2B | 0.39058095 |
| 152 | ERBB2 | 0.38528740 |
| 153 | ROCK2 | 0.38515105 |
| 154 | PRKAA2 | 0.37623120 |
| 155 | WNK4 | 0.37019747 |
| 156 | PKN1 | 0.36371799 |
| 157 | RPS6KA4 | 0.35274335 |
| 158 | MAP3K1 | 0.34865310 |
| 159 | TTN | 0.34829575 |
| 160 | PRKCQ | 0.34580683 |
| 161 | FES | 0.34531700 |
| 162 | MAP2K1 | 0.34270406 |
| 163 | NTRK2 | 0.33548636 |
| 164 | CAMK1G | 0.32642160 |
| 165 | PRKCB | 0.32255602 |
| 166 | BCKDK | 0.31861084 |
| 167 | EIF2AK2 | 0.31402025 |
| 168 | MAPKAPK2 | 0.30777478 |
| 169 | GRK7 | 0.30107521 |
| 170 | SMG1 | 0.29937925 |
| 171 | KIT | 0.28004082 |
| 172 | MKNK1 | 0.27852789 |
| 173 | RPS6KA5 | 0.27768205 |
| 174 | MAPK8 | 0.23346455 |
| 175 | PRKCZ | 0.21926951 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 5.81403626 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.57313305 |
| 3 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.24234135 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.08637481 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.02447999 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 3.00109618 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.93236247 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.85258650 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.80800116 |
| 10 | DNA replication_Homo sapiens_hsa03030 | 2.75635259 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.62689125 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.51127672 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.49030353 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.42492722 |
| 15 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.32672443 |
| 16 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.30834992 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24648620 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 2.24222697 |
| 19 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.15650447 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.12088240 |
| 21 | Base excision repair_Homo sapiens_hsa03410 | 1.93850650 |
| 22 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.91485544 |
| 23 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84854998 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.83715321 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.82643210 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.80534715 |
| 27 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79149651 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.75730639 |
| 29 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.72380980 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.68470689 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.68342153 |
| 32 | Leishmaniasis_Homo sapiens_hsa05140 | 1.67120226 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.64188358 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.56387256 |
| 35 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50159710 |
| 36 | Protein export_Homo sapiens_hsa03060 | 1.47717470 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.44045102 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.42302608 |
| 39 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.41419239 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.41069713 |
| 41 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40134736 |
| 42 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40133208 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.37105374 |
| 44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.33947078 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29683171 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.28990368 |
| 47 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26369198 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.25333563 |
| 49 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.23954934 |
| 50 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.23396302 |
| 51 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22102080 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.21106250 |
| 53 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.20131921 |
| 54 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19217666 |
| 55 | Basal transcription factors_Homo sapiens_hsa03022 | 1.17383823 |
| 56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.16108865 |
| 57 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13932844 |
| 58 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.11044823 |
| 59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10977383 |
| 60 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.09717575 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08931350 |
| 62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.06237966 |
| 63 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.05918470 |
| 64 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05887083 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 1.05209025 |
| 66 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05128054 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04572005 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.03481450 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02956027 |
| 70 | Carbon metabolism_Homo sapiens_hsa01200 | 1.02644549 |
| 71 | Purine metabolism_Homo sapiens_hsa00230 | 1.01439135 |
| 72 | Cell cycle_Homo sapiens_hsa04110 | 1.01340071 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.98442999 |
| 74 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.97418505 |
| 75 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97175371 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94281842 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93579823 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90013343 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.89560257 |
| 80 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.88698716 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.88255495 |
| 82 | Salivary secretion_Homo sapiens_hsa04970 | 0.87872646 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.87595843 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86080116 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.83979553 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.83354696 |
| 87 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82230074 |
| 88 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.81316719 |
| 89 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81174024 |
| 90 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80028819 |
| 91 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78746065 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76618223 |
| 93 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.75281042 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74969256 |
| 95 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74725365 |
| 96 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.74523259 |
| 97 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74316426 |
| 98 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.74040918 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.73372035 |
| 100 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.73325051 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73245300 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.72877729 |
| 103 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72570496 |
| 104 | Tuberculosis_Homo sapiens_hsa05152 | 0.71769025 |
| 105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71016771 |
| 106 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.70563673 |
| 107 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.69868956 |
| 108 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69536628 |
| 109 | GABAergic synapse_Homo sapiens_hsa04727 | 0.69049719 |
| 110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69041041 |
| 111 | Long-term potentiation_Homo sapiens_hsa04720 | 0.68475064 |
| 112 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67446673 |
| 113 | Legionellosis_Homo sapiens_hsa05134 | 0.67360837 |
| 114 | Melanoma_Homo sapiens_hsa05218 | 0.65816942 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.65548846 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.64893322 |
| 117 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.62825676 |
| 118 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62089661 |
| 119 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62063381 |
| 120 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.61706850 |
| 121 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.61702869 |
| 122 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60790563 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60764135 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60185991 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.60113147 |
| 126 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.60049267 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.59166652 |
| 128 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.58345565 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.57757473 |
| 130 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.56549369 |
| 131 | Circadian entrainment_Homo sapiens_hsa04713 | 0.56287806 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55513466 |
| 133 | Apoptosis_Homo sapiens_hsa04210 | 0.55321588 |
| 134 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.54602547 |
| 135 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.53304978 |
| 136 | Morphine addiction_Homo sapiens_hsa05032 | 0.53107864 |
| 137 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52875366 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52857256 |
| 139 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.50719948 |
| 140 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50164414 |
| 141 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.48795441 |
| 142 | Lysine degradation_Homo sapiens_hsa00310 | 0.47297782 |
| 143 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45069418 |
| 144 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44889502 |
| 145 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44629003 |
| 146 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43074813 |
| 147 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42078525 |
| 148 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.41984001 |
| 149 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41309492 |
| 150 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.41155556 |
| 151 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.40928762 |
| 152 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.40863838 |
| 153 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39789063 |
| 154 | Influenza A_Homo sapiens_hsa05164 | 0.39727531 |
| 155 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39086295 |
| 156 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.37658136 |
| 157 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.36794939 |
| 158 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.36720748 |
| 159 | Axon guidance_Homo sapiens_hsa04360 | 0.36082411 |
| 160 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.35786816 |
| 161 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35751377 |
| 162 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34876280 |
| 163 | Hepatitis B_Homo sapiens_hsa05161 | 0.34602788 |
| 164 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32437004 |
| 165 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.31499589 |
| 166 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.31344310 |
| 167 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.30638621 |
| 168 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30616516 |
| 169 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.29932131 |
| 170 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.28480951 |
| 171 | Measles_Homo sapiens_hsa05162 | 0.28109960 |
| 172 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.27863897 |
| 173 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27066246 |
| 174 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.26749706 |
| 175 | Melanogenesis_Homo sapiens_hsa04916 | 0.25973021 |
| 176 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.25959144 |
| 177 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.25165508 |
| 178 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.24951211 |

